Your browser doesn't support javascript.
loading
Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.
Howard, Sasha R; Freeston, Sarah; Harrison, Barney; Izatt, Louise; Natu, Sonali; Newbold, Kate; Pomplun, Sabine; Spoudeas, Helen A; Wilne, Sophie; Kurzawinski, Tom R; Gaze, Mark N.
Afiliación
  • Howard SR; Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, UK.
  • Freeston S; Department of Paediatric Endocrinology, Barts Health NHS Trust, London, UK.
  • Harrison B; Whipps Cross Hospital, Barts Health NHS Trust, London, UK.
  • Izatt L; Retired Endocrine Surgeon, Sheffield, UK.
  • Natu S; Department of Clinical and Cancer Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Newbold K; Department of Pathology, University Hospital of North Tees and Hartlepool NHS Foundation Trust, Stockton-on-Tees, UK.
  • Pomplun S; Department of Clinical Oncology, Royal Marsden Hospital Foundation Trust, London, UK.
  • Spoudeas HA; Department of Pathology, University College London Hospital NHS Foundation Trust, London, UK.
  • Wilne S; Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Kurzawinski TR; Department of Paediatric Oncology, Nottingham University Hospital's NHS Trust, Nottingham, UK.
  • Gaze MN; Department of Endocrine Surgery, University College London Hospitals NHS Foundation Trust, London, UK.
Endocr Relat Cancer ; 29(11): G1-G33, 2022 11 01.
Article en En | MEDLINE | ID: mdl-35900783
This guideline is written as a reference document for clinicians presented with the challenge of managing paediatric patients with differentiated thyroid carcinoma up to the age of 19 years. Care of paediatric patients with differentiated thyroid carcinoma differs in key aspects from that of adults, and there have been several recent developments in the care pathways for this condition; this guideline has sought to identify and attend to these areas. It addresses the presentation, clinical assessment, diagnosis, management (both surgical and medical), genetic counselling, follow-up and prognosis of affected patients. The guideline development group formed of a multi-disciplinary panel of sub-speciality experts carried out a systematic primary literature review and Delphi Consensus exercise. The guideline was developed in accordance with The Appraisal of Guidelines Research and Evaluation Instrument II criteria, with input from stakeholders including charities and patient groups. Based on scientific evidence and expert opinion, 58 recommendations have been collected to produce a clear, pragmatic set of management guidelines. It is intended as an evidence base for future optimal management and to improve the quality of clinical care of paediatric patients with differentiated thyroid carcinoma.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Child / Humans País/Región como asunto: Europa Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Adult / Child / Humans País/Región como asunto: Europa Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article